false
--05-31
0001718500
0001718500
2024-01-12
2024-01-12
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported): January 12, 2024
REVIV3
PROCARE COMPANY
(Exact
name of registrant as specified in its charter)
|
|
|
|
|
Delaware |
|
000-56351 |
|
47-4125218 |
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File
Number) |
|
(IRS
Employer
Identification
No.) |
|
|
|
|
|
901
Fremont Avenue, Unit 158, Alhambra, CA |
|
91803 |
(Address
of principal executive offices) |
|
(Zip
Code) |
Registrant’s
telephone number, including area code: (888) 638-8883
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
|
☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Exchange Act:
Title
of each class |
Trading
Symbol(s) |
Name
of each exchange on which registered |
None |
N/A |
N/A |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item
3.03 | Material
Modification to Rights of Security Holders. |
To
the extent required by Item 3.03 of Form 8-K, the information contained in Item 5.03 of this Current Report on Form 8-K is incorporated
herein by reference.
| Item
5.03 | Amendments
to Articles of Incorporation or Bylaws; Change in Fiscal Year. |
On
January 12, 2024, Reviv3 Procare Company (the “Company”) filed a Certificate of Amendment (the “Amendment”) to
the Company’s Amended and Restated Certificate of Incorporation, with the Delaware Secretary of State to implement a reverse stock
split of the Company’s issued shares of common stock, par value $0.0001 per share at a ratio of one (1) for twenty (20) approved by the
Company’s Board of Directors, effective at 12:01 a.m. Eastern Time on January 16, 2024 (the “Reverse Stock Split”). As
a result of the Reverse Stock Split, every twenty (20) shares of the Company’s issued common stock will automatically be combined
into one (1) share of common stock. The Reverse Stock Split will affect all stockholders uniformly and will not alter any stockholders’
percentage interest in the Company’s common stock, except to the extent that the Reverse Stock Split results in any of our stockholders
receiving whole shares in lieu of fractional shares as further described below. Any fractional shares resulting from the Reverse Stock
Split will be rounded up to the nearest whole share. Proportionate adjustments for the Reverse Stock Split will be made to the exercise
prices and number of shares issuable under the Company’s equity incentive plan, and the number of shares underlying outstanding
equity awards, as applicable. Similarly, the conversion provisions of the Company’s Series A Preferred Stock will also be proportionately
adjusted in connection with the Reverse Stock Split. The Reverse Stock Split will not change the par value of the common stock, modify
any voting rights or other terms of the common stock, or change the number of authorized shares of the Company.
The
Company expects that its common stock will begin trading on a post-Reverse Stock Split basis under the Company’s existing trading
symbol “RVIV” when the market opens on January 16, 2024. The ticker symbol will temporarily be appended with “D”
to signify the effectiveness of the Reverse Stock Split. The new CUSIP number for the Company’s common stock post-Reverse Stock Split
is 76151R206.
The
foregoing summary of the Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of
the Amendment, a copy of which is attached hereto as Exhibit 3.1 and is incorporated herein by reference.
On
January 16, 2024, the Company issued a press release announcing the Reverse Stock Split. A copy of the press release is attached as Exhibit
99.1 to this report.
Cautionary
Note Regarding Forward Looking Statements
This
Current Report on Form 8-K contains certain “forward-looking statements” within the meaning of Section 27A of the Securities
Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements represent
our expectations, beliefs, intentions or strategies concerning future events, including, but not limited to, any statements regarding
the Reverse Stock Split, of which is subject to various risks and uncertainties. When used in this Current Report and Form 8-K,
the words or phrases “will,” “expects,” or similar expressions and variations thereof are intended to identify
such forward-looking statements. However, any statements contained in this Current Report on Form 8-K that are not statements of historical
fact may be deemed to be forward-looking statements. Furthermore, such forward-looking statements speak only as of the date of this Current
Report and Form 8-K. We caution that these statements by their nature involve risks and uncertainties, certain of which are beyond our
control, and actual results may differ materially depending on a variety of important factors. For example, there can be no assurance
that the Reverse Stock Split will be successful. These forward-looking statements are not guarantees of our future performance and involve
risks, uncertainties, estimates and assumptions that are difficult to predict. We do not assume the obligation to update any forward-looking
statement, except as required by applicable law.
| Item
9.01 | Financial
Statements and Exhibits. |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
|
REVIV3
PROCARE COMPANY |
|
|
Date:
January 16, 2024 |
/s/
Jeff Toghraie |
|
Name: |
Jeff
Toghraie |
|
Title: |
Chief
Executive Officer |
|
|
|
CERTIFICATE OF AMENDMENT
TO THE AMENDED AND RESTATED
CERTIFICATE OF INCORPORATION
OF
REVIV3 PROCARE COMPANY
REVIV3 PROCARE COMPANY (the “Corporation”),
a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “DGCL”),
does hereby certify as follows:
|
1. |
This Certificate of Amendment (the “Certificate of Amendment”) amends the provisions of the Corporation’s Amended and Restated Certificate of Incorporation filed with the Secretary of State of the State of Delaware on June 9, 2015, as amended by that Certificate of Amendment filed on June 13, 2022 (the “Certificate of Incorporation”). |
|
2. |
Paragraph A of Article IV of the Certificate of Incorporation of the Corporation shall be amended to insert the following immediately following the first sentence of Paragraph A of Article IV as follows: |
“As of the Effective
Time, a one-for-twenty reverse stock split of the Corporation’s Common Stock shall become effective, pursuant to which each twenty
(20) shares of Common Stock issued and held of record by each stockholder of the Corporation immediately prior to the Effective Time shall
be reclassified and combined into one (1) validly issued, fully-paid and nonassessable share of Common Stock automatically and without
any action by the holder thereof upon the Effective Time and shall represent one share of Common Stock from and after the Effective Time
(such reclassification and combination of shares, the “Reverse Stock Split”). The par value of the Corporation’s
Common Stock following the Reverse Stock Split shall remain at $0.0001 per share.
No fractional shares
of Common Stock shall be issued as a result of the Reverse Stock Split. In lieu thereof, any holder who would otherwise be entitled to
a fractional share of Common Stock as a result of the Reverse Stock Split, following the Effective Time, shall be entitled to receive
one (1) additional whole share of Common Stock; provided, however, that, whether or not fractional shares would be issuable as a result
of the Reverse Stock Split shall be determined on the basis of (a) the total number of shares of Common Stock that were issued and outstanding
immediately prior to the Effective Time and (b) the aggregate number of shares of Common Stock after the Effective Time into which the
shares of Common Stock have been reclassified; and with respect to holders of shares of Common Stock in book-entry form in the records
of the Corporation’s transfer agent that were issued and outstanding immediately prior to the Effective Time, any holder who would
otherwise be entitled to a fractional share of Common Stock as a result of the Reverse Stock Split, following the Effective Time, shall
be entitled to receive one (1) additional share of Common Stock automatically and without any action by the holder.
Beginning at the Effective
Time, each certificate representing pre-Reverse Stock Split shares of Common Stock will be deemed for all corporate purposes to evidence
ownership of post-Reverse Stock Split shares.”
|
3. |
Pursuant to Section 242 of the DGCL, the Board of Directors of the Corporation has duly adopted, and a majority of the outstanding stock entitled to vote thereon has duly approved, the amendment to the Certificate of Incorporation set forth in this Certificate of Amendment. |
|
4. |
This Certificate of Amendment shall become effective as of January 16, 2024 at 12:01 a.m. Eastern Time (the “Effective Time”). |
|
5. |
All other provisions of the Certificate of Incorporation shall remain in full force and effect. |
IN WITNESS WHEREOF, the
Corporation has caused this Certificate of Amendment to be executed by the undersigned duly authorized officer this 12th day of January,
2024.
|
REVIV3 PROCARE COMPANY |
|
|
/s/ Jeff Toghraie |
|
|
Name: Jeff Toghraie |
|
|
Title: Chief Executive Officer |
|
REVIV3
PREPARES FOR NYSE AMERICAN LISTING WITH
REVERSE STOCK SPLIT
1-for-20
Reverse Stock Split Intended to Meet NYSE American Listing Requirements
LOS
ANGELES, CA, January 16, 2024 (GLOBE NEWSWIRE) -- Reviv3 Procare Company (“Reviv3,” “we,” “us,” “our,”
or the “Company”) (OTCQB: RVIV), an emerging global consumer products company for AXIL® hearing protection and enhancement
products and Reviv3® hair and skin care products, today announced that on January 12, 2024, it filed a Certificate of Amendment to
its Amended and Restated Certificate of Incorporation to effect a one (1) for twenty (20) reverse stock split of its common stock, par
value $00001 per share (the “Common Stock”, effective as of 12:01 a.m. Eastern Standard Time on January 16, 2024 (the “Reverse
Stock Split”). The Reverse Stock Split was completed in accordance with the authorization provided by the written consent of a
majority of the Company’s stockholders holding a majority of our issued and outstanding shares of the Common Stock on October 31,
2023 and disclosed in a Definitive Information Statement on Schedule 14C filed with the Securities and Exchange Commission (the “SEC”)
on December 4, 2023.
As
previously disclosed, the Company has applied for listing on the NYSE American stock Exchange (the “NYSE American”). The
Reverse Stock Split was implemented in connection with the NYSE American listing application. The NYSE American requires, among other
items, an initial bid price of least $3.00 per share. Reducing the number of outstanding shares of our Common Stock should, absent other
factors, increase the per share market price of our Common Stock to a price that allows us to meet the NYSE American initial listing
requirements. The Company continues to take steps to satisfy other requirements, but there can be no assurance that the Company will
meet all the requirements for its NYSE American listing.
The
Common Stock will begin trading on a split-adjusted basis under the existing trading symbol “RVIV” when the market opens
on January 16, 2024. The ticker symbol will temporarily be appended with “D” to signify the effectiveness of the Reverse Stock
Split.
“This
reverse split represents another major step toward our Common Stock being traded on a listed U.S. exchange,” commented Reviv3 CEO,
Jeff Toghraie. “We believe a NYSE American listing will elevate our visibility and broaden awareness of our success in the financial
community, particularly with institutional and retail investors, and provide our shareholders with greater liquidity and enhance shareholder
value. These benefits will be timely, as we prepare to effect a corporate rebranding to “AXIL Brands, Inc.” in connection
with the anticipated exchange listing, and the introduction of a number of new hearing enhancement and protection products expected to
be released this calendar year.”
The
Reverse Stock Split will affect all of our stockholders uniformly and will not affect any stockholder’s percentage ownership interests
in us, except to the extent that the Reverse Stock Split results in any of our stockholders owning a fractional share, which will be
rounded up to the nearest whole share. The Reverse Stock Split will reduce the number of issued and outstanding Common Stock from 117,076,949
pre-split shares to 5,853,936 post-split shares, subject to adjustments for rounding of fractional shares. Proportional adjustments will
be made to any outstanding preferred shares or options.
About
Reviv3
Reviv3
Procare Company (OTCQB: RVIV) is an emerging global e-commerce consumer products company. The Company is a manufacturer and marketer
of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, under the AXIL® brand and premium
hair and skincare products under its in-house Reviv3 Procare brand - selling products in the United States, Canada, the European Union
and throughout Asia. To learn more, please visit the Company’s website at www.reviv3.com and, for the AXIL® brand,
visit www.goaxil.com.
Forward-Looking
Statements
This
press release contains a number of forward-looking statements within the meaning of the federal securities laws. The use of words such
as “intend,” “continue,” “will,” “prepare,” “should,” and “would,”
among others, generally identify forward-looking statements. These forward-looking statements are based on currently available information,
and management’s beliefs, projections, and current expectations, and are subject to a number of significant risks and uncertainties,
many of which are beyond management’s control and may cause Reviv3’s results, performance or achievements to differ materially
from any future results, performance or achievements expressed or implied by these forward-looking statements including the risk that
the Reverse Stock Split won’t increase the price of our Common Stock and otherwise have its intended effect and risks associated
with listing our shares on NYSE American.. There can be no assurance as to any of these matters, and potential investors are urged to
consider these factors carefully in evaluating the forward-looking statements. Other important factors that may cause actual results
to differ materially from those expressed in the forward-looking statements are discussed in the Company’s filings with the SEC.
These forward-looking statements speak only as of the date hereof. Except as required by law, Reviv3 does not assume any obligation to
update or revise these forward-looking statements for any reason, even if new information becomes available in the future.
For
a discussion of these risks and uncertainties, please see our filings with the SEC. Our public filings with the SEC are available from
commercial document retrieval services and at the website maintained by the SEC at http://www.sec.gov.
Investor
Relations:
Reviv3
Investor Relations Team
(888)
638-8883
investors@reviv3.com
v3.23.4
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionEnd date of current fiscal year in the format --MM-DD.
+ References
+ Details
Name: |
dei_CurrentFiscalYearEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:gMonthDayItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 2 such as Street or Suite number
+ References
+ Details
Name: |
dei_EntityAddressAddressLine2 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Section 14a -Number 240 -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
Reviv3 Procare (QB) (USOTC:RVIV)
Historical Stock Chart
From Apr 2024 to May 2024
Reviv3 Procare (QB) (USOTC:RVIV)
Historical Stock Chart
From May 2023 to May 2024